Baldado, Rolando .
HRN: 21-88-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/10/2022
09/17/2022
IV
500 Mg
Q 8 HRS
T/C Intraabdomin Abcess With Fistulous Formation
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes